Skip To Main Content
Peter Verhamme on Muck Rack

Peter Verhamme

As seen in: Color Research & Application, Wiley Online Library, British Pharmacological Society, European Journal of Hospital Pharmacy, Educational Studies, Expert Review of Anticancer Therapy, The New England Journal of Medicine, Medscape, The European Heart Journal, American Society for Microbiology (ASM) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Peter

Contact Peter, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Blood pressure and renal function responses in workers exposed to lead for up to six years

|
By Yu-Ling Yu, Wen-Yi Yang, Peter Verhamme, De-Wei An
| Wiley Online Library Verified
1 INTRODUCTION Lead is a widespread environmental toxicant. Although previous publications have demonstrated the significant associations of lead exposure with the risks of hypertension1, 2 or renal function (RF) decline,3-6 these studies, either in environmental2-5 or occupational1, 6 settings, were based on high-level lead exposure, had a cross-sectional design, or gave insufficient consideration to previous exposure or other confounders.
Open in Who Shared Issue with article?

Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer‐associated thrombosis

|
By Thomas Vanassche, Eric Van Cutsem, Lucas Van Aelst, Peter Verhamme
| British Pharmacological Society
REVIEW ARTICLE Funding information: LVDL has received funding from the Clinical Research Fund of the University Hospitals Leuven (Leuven, Belgium). TVA is holder of a senior clinical research fellowship from the Flanders Research Foundation (FWO; 1843418N) Abstract Drug–drug interactions (DDIs) are common in cancer management and complicate the choice of anticoagulation in cancer-associated thrombosis. Cancer confers an increased risk of thrombotic events.
Open in Who Shared Issue with article?

From bad to worse: the shortage of fibrinolytics

|
By Jens Neefs, Thomas Vanassche, Robin Lemmens, Peter Verhamme
| European Journal of Hospital Pharmacy Verified
From bad to worse: the shortage of fibrinolytics Free http://orcid.org/0000-0001-5195-1891Lorenz Roger Van der Linden1,2, Jens Neefs1, Thomas Vanassche3,4, Robin Lemmens5,6, Peter Verhamme3,4 1 Hospital Pharmacy Department, UZ Leuven, Leuven, Flanders, Belgium 2 Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Flanders, Belgium 3 Department of Cardiovascular Sciences, KU Leuven, Leuven, Flanders, Belgium 4 Department of Cardiology, UZ Leuven, Leuven, Flanders,...
Open in Who Shared Issue with article?
See all 16 articles